Should you buy EYES ETF?
Last updated:
Based on market data through , StockInvest.us rates Second Sight Medical Products Inc (EYES) as a Strong Buy Candidate with a technical score of 6.46 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Buy signal since
- Price since signal Up 1.30%
- 3-month trend forecast Up 10.69%
- Bullish trend confirmed on both short and long timeframes
- +11.7% YTD performance
- +11.7% price growth over the last year
Green day on Monday for Second Sight Medical Products Inc
(Market data through Aug 10, 2026)
The Second Sight Medical Products Inc ETF price gained 1.30% on the last trading day (Monday, 10th Aug 2026), rising from $29.60 to $29.98. During the last trading day the ETF fluctuated 0.637% from a day low at $29.79 to a day high of $29.98. The price has risen in 7 of the last 10 days and is up by 17.31% over the past 2 weeks. Volume fell on the last day by -84 thousand shares and in total, 5 thousand shares were bought and sold for approximately $161.62 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Given the current short-term trend, the ETF is expected to rise 10.69% during the next 3 months and, with a 90% probability hold a price between $29.69 and $33.18 at the end of this 3-month period.
EYES Signals & Forecast
The Second Sight Medical Products Inc ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the ETF. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $28.54 and $17.35. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, July 23, 2026, and so far it has risen 19.10%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for Second Sight Medical Products Inc ETF
Second Sight Medical Products Inc finds support from accumulated volume at $29.60 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This ETF has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the ETF moved $0.190 between high and low, or 0.637%. For the last week the ETF has had daily average volatility of 1.60%.
Our recommended stop-loss: $29.08 (-3.00%) (This ETF has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 12 days ago.)
Trading Expectations (EYES) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Second Sight Medical Products Inc to open at $29.92, and during the day (based on 14 day Average True Range), to move between $29.65 and $30.31, which gives a possible trading interval of +/-$0.669 (+/-2.26%) up or down from last closing price. If Second Sight Medical Products Inc takes out the full calculated possible swing range there will be an estimated 2.26% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $29.60, some $0.384 (1.28%) from the current price of $29.98, our system finds the risk reward attractive.
Is Second Sight Medical Products Inc ETF A Buy?
Second Sight Medical Products Inc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
Current score:
6.463
Strong Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $29.92 ( 0.211%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
EYES Performance
Trading levels for EYES
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 30.11 | 0.422% |
| R2 | 30.03 | 0.180% |
| R1 | 29.99 | 0.0308% |
| Price | 29.98 | |
| S1 | 29.84 | -0.453% |
| S2 | 29.80 | -0.602% |
| S3 | 29.73 | -0.84% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 29.98 | |
| S1 | 29.60 | -1.28% |
| S2 | 26.67 | -11.03% |
| S3 | 26.47 | -11.71% |
FAQ
Click here for our free guide on how to buy Second Sight Medical Products Inc ETF.
Buy EYES